Pharma News - Chemdiv

Moderna starts clinical trial of booster shot targeting omicron Covid variant

Moderna started a clinical trial to study the safety and effectiveness of a booster shot that specifically targets the omicron Covid variant, the company announced Wednesday. ...

Big Insulin Makers Spent Big Money on Lobbying in 2021

Two of the top producers of insulin increased their lobbying efforts last year amid public cries for pricing reform for all drugs, but insulin in particular.

FDA Revokes EUAs for Two Monoclonal Antibodies Shown to be Ineffective Against Omicron

The FDA has revoked the Emergency Use Authorization (EUA) for Regeneron’s REGEN-COV (casirivimab plus imdevimab) and Eli Lilly’s (bamlanivimab and etesevimab), both monoclonal antibodies that b...

J&J Forecasts Sales of $3.5 Billion for Its COVID-19 Jab in 2022

Though it’s the least-administered COVID-19 vaccine of the three approved in the U.S., Johnson & Johnson (J&J) said it believes global sales of its COVID-19 vaccine will reach $3.5 billio...

Seagen Canada Announces Availability of PADCEV to Treat Advanced Bladder Cancer

Seagen Canada announced the commercial availability of PADCEV® (enfortumab vedotin) for the treatment of adult patients with unresectable locally advanced or metastatic urothelial cancer (mUC) wh...

Innovative phase 2 trial targets advanced liver cancer

The UCL study will evaluate the safety and effectiveness of MTL-CEBPA in combination with second line standard of care sorafenib versus the use of sorafenib in isolation ...

AbbVie’s Skyrizi Wins FDA Approval for Psoriatic Arthritis

The FDA has approved AbbVie’s Skyrizi (risankizumab-rzaa) for treating adults with psoriatic arthritis, an inflammatory disease that afflicts an estimated 30 percent of psoriasis sufferers. ...

The FDA expands its approval of remdesivir to patients who are not hospitalized

The treatment must be given via intravenous infusion over three consecutive days, generally at a hospital or clinic.

UCB wins permit to market psoriasis drug in Japan

Belgian pharmaceuticals company UCB has been given permission to market its treatment for psoriasis, Bimzelx (bimekizumab) in Japan, the company announced today. ...

FDA grants fast track status for new Alzheimer’s drug lecanemab

Two health care companies – one based in Massachusetts called Biogen and its Japanese partner Eisai Co. – recently were granted “fast track” approval by the U.S. Food and Drug Administratio...

Elon Musk’s Neuralink is hiring a clinical trial director

Elon Musk’s brain-machine interface company Neuralink has a new job posting for a clinical trial director, a position that could help the company move towards its stated goal of testing its brain...

Santa Cruz company gets on FDA fast track for pathogen sequencing method approval

Nearly 3,000 devices receive approval from the FDA each year, according to Pathogenomix Chairman Chris Risley, but only 75 receive a Breakthrough Device Designation. ...

Pharma News, 2022